Screener
AbCellera Biologics Inc. ABCL Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $135.62M.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s total debt?
- AbCellera Biologics Inc. (ABCL) reported total debt of $135.62M in Q2 2026.
- How has AbCellera Biologics Inc.'s total debt changed year-over-year?
- AbCellera Biologics Inc.'s total debt decreased by 4.5% year-over-year, from $142.08M to $135.62M.
- What is the long-term trend for AbCellera Biologics Inc.'s total debt?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total debt has grown at a 99.1% compound annual growth rate (CAGR), from $4.58M to $143.22M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about AbCellera Biologics Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude